These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19659629)

  • 1. Cardioversion for atrial fibrillation: treatment options and advances.
    Reiffel JA
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1073-84. PubMed ID: 19659629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vernakalant hydrochloride for the treatment of atrial fibrillation.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-pharmacologic treatment of atrial fibrillation].
    Csanádi Z; Fazekas T; Varró A
    Orv Hetil; 2003 Jun; 144(26):1279-89. PubMed ID: 12894672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation: current trends].
    Bonhorst D
    Rev Port Cardiol; 2000 Jun; 19(6):717-23. PubMed ID: 10961097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiarrhythmic drugs for prevention of atrial fibrillation.
    Goldstein RN; Stambler BS
    Prog Cardiovasc Dis; 2005; 48(3):193-208. PubMed ID: 16271945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique.
    Santini L; Forleo GB; Topa A; Romeo F; Santini M
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):601-10. PubMed ID: 16076271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation: cure or treat?
    Forleo GB; Tondo C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern trends in the treatment of patients with atrial fibrillation].
    Abuladze G; Mamamtavrishvili N; Jashi I; Kantaria D; Ambroladze N
    Georgian Med News; 2005 Apr; (121):59-61. PubMed ID: 15908727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical challenge of the atrial fibrillation].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
    Wyse DG
    Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vernakalant in the management of atrial fibrillation.
    Cheng JW
    Ann Pharmacother; 2008 Apr; 42(4):533-42. PubMed ID: 18334607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint.
    Boriani G; Diemberger I; Biffi M; Martignani C; Ziacchi M; Bertini M; Valzania C; Bronzetti G; Rapezzi C; Branzi A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):422-33. PubMed ID: 17367364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of atrial fibrillation therapy.
    Dorian P
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S11-6. PubMed ID: 16939433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.